← Back to Clinical Trials
Recruiting NCT05258448

COr Loco-regional Advanced Lung Cancer Treated With Chemo-radiotherapy (COLA)

Trial Parameters

Condition Cardiac Toxicity
Sponsor Odense University Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 100
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2015-08
Completion 2024-08
Interventions
Chemoradiotherapy

Brief Summary

Patients with loco-regional NSCLC planned for curative treatment with chemoradiotherapy will be invited to participate in a prospective study; besides routine treatment, the patients will be followed with an ECG and cardiac MR for at least two years after radiotherapy treatment.

Eligibility Criteria

Inclusion Criteria: * Age ≥ 18 Years * Inoperable and histologically/cytologically verified NSCLC. * Planned treatment with curative intent. * Capable of completing study procedures ECG and Cardiac MR. * Able of giving written and informed consent before study procedures are initiated. Exclusion Criteria: * Vulnerable patients. * Patients with operable devices as pacemaker/ICD and cochlear implant or other conditions where MR scan is contraindicated. * Claustrophobia.

Related Trials